{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:19:35Z","timestamp":1787959175321,"version":"build-2784847793"},"reference-count":54,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Whole-body magnetic resonance imaging (WB-MRI) is being employed with increasing frequency to evaluate a broader spectrum of patients with diverse types of cancer and for cancer screening purposes. While clinical guidelines support its use, a standardized radiological approach is still lacking. To improve consistency in the acquisition, interpretation, and reporting of WB-MRI examinations, three reporting and data systems (RADSs) have been recently suggested: METastasis Reporting and Data System for Prostate Cancer (MET-RADS-P), Myeloma Response Assessment and Diagnosis System (MY-RADS), and Oncologically Relevant Findings Reporting and Data System (ONCO-RADS). MET-RADS-P was developed to stage and monitor men with advanced prostate cancer using WB-MRI. It has emerged as a reliable imaging biomarker for predicting metastatic disease progression and assessing treatment response. MY-RADS was developed to stage and monitor patients with multiple myeloma using WB-MRI, emerging as a prognostic imaging biomarker. However, the evidence regarding inter-reader agreement for MY-RADS is currently limited. ONCO-RADS was developed to standardize the use of WB-MRI for cancer screening in individuals with cancer predisposition syndromes and in the general population. While initial findings are promising, the evidence supporting its use remains limited. To further validate and expand upon these promising preliminary findings, additional large-scale, prospective, multicenter studies are necessary.<\/jats:p>","DOI":"10.3390\/cancers17020275","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T04:55:19Z","timestamp":1737003319000},"page":"275","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The Whole-Body MRI Reporting and Data System Guidelines for Prostate Cancer (MET-RADS-P), Multiple Myeloma (MY-RADS), and Cancer Screening (ONCO-RADS)"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4067-7118","authenticated-orcid":false,"given":"Marco","family":"Parillo","sequence":"first","affiliation":[{"name":"Radiology, Multizonal Unit of Rovereto and Arco, APSS Provincia Autonoma Di Trento, 38123 Trento, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0149-0801","authenticated-orcid":false,"given":"Carlo Augusto","family":"Mallio","sequence":"additional","affiliation":[{"name":"Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Roma, Italy"},{"name":"Research Unit of Diagnostic Imaging and Interventional Radiology, Department of Medicine and Surgery, Universit\u00e0 Campus Bio-Medico di Roma, 00128 Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ejrad.2013.11.017","article-title":"Diagnostic Value of Whole-Body Diffusion-Weighted Magnetic Resonance Imaging for Detection of Primary and Metastatic Malignancies: A Meta-Analysis","volume":"83","author":"Li","year":"2014","journal-title":"Eur. J. Radiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.2214\/ajr.169.6.9393186","article-title":"A Comparison of Whole-Body turboSTIR MR Imaging and Planar 99mTc-Methylene Diphosphonate Scintigraphy in the Examination of Patients with Suspected Skeletal Metastases","volume":"169","author":"Eustace","year":"1997","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/(SICI)1522-2586(200004)11:4<343::AID-JMRI1>3.0.CO;2-P","article-title":"Turbo STIR Magnetic Resonance Imaging as a Whole-Body Screening Tool for Metastases in Patients with Breast Carcinoma: Preliminary Clinical Experience","volume":"11","author":"Walker","year":"2000","journal-title":"J. Magn. Reson. Imaging"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.3332\/ecancer.2021.1164","article-title":"Whole-Body Magnetic Resonance Imaging: Technique, Guidelines and Key Applications","volume":"15","author":"Summers","year":"2021","journal-title":"Ecancermedicalscience"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"W336","DOI":"10.2214\/AJR.17.17984","article-title":"Whole-Body MRI: Current Applications in Oncology","volume":"209","author":"Morone","year":"2017","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1007\/s11547-024-01851-6","article-title":"Whole-Body MRI in Oncology: Acquisition Protocols, Current Guidelines, and Beyond","volume":"129","author":"Zugni","year":"2024","journal-title":"Radiol. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.annonc.2020.06.011","article-title":"Prostate Cancer: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up","volume":"31","author":"Parker","year":"2020","journal-title":"Ann. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1200\/JCO.19.02757","article-title":"Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline","volume":"38","author":"Trabulsi","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e302","DOI":"10.1016\/S1470-2045(19)30309-2","article-title":"International Myeloma Working Group Consensus Recommendations on Imaging in Monoclonal Plasma Cell Disorders","volume":"20","author":"Hillengass","year":"2019","journal-title":"Lancet Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1158\/1078-0432.CCR-17-0408","article-title":"Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome","volume":"23","author":"Kratz","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1158\/1078-0432.CCR-17-0574","article-title":"Clinical Management and Tumor Surveillance Recommendations of Inherited Mismatch Repair Deficiency in Childhood","volume":"23","author":"Tabori","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1158\/1078-0432.CCR-17-0547","article-title":"Von Hippel-Lindau and Hereditary Pheochromocytoma\/Paraganglioma Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood","volume":"23","author":"Rednam","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40644-020-00315-0","article-title":"Whole-Body Magnetic Resonance Imaging (WB-MRI) for Cancer Screening in Asymptomatic Subjects of the General Population: Review and Recommendations","volume":"20","author":"Zugni","year":"2020","journal-title":"Cancer Imaging"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"764","DOI":"10.3390\/surgeries5030061","article-title":"Brain Tumor Reporting and Data System (BT-RADS) for the Surveillance of Adult-Type Diffuse Gliomas after Surgery","volume":"5","author":"Parillo","year":"2024","journal-title":"Surgeries"},{"key":"ref_15","unstructured":"(2024, December 04). Reporting and Data Systems. Available online: https:\/\/www.acr.org\/Clinical-Resources\/Reporting-and-Data-Systems."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Parillo, M., and Quattrocchi, C.C. (2025). Node Reporting and Data System 1.0 (Node-RADS) for the Assessment of Oncological Patients\u2019 Lymph Nodes in Clinical Imaging. J. Clin. Med., 14.","DOI":"10.3390\/jcm14010263"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10334-023-01113-y","article-title":"The Role of Gadolinium-Based Contrast Agents in Magnetic Resonance Imaging Structured Reporting and Data Systems (RADS)","volume":"37","author":"Parillo","year":"2024","journal-title":"MAGMA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.eururo.2016.05.033","article-title":"METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-Body Magnetic Resonance Imaging-Based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer","volume":"71","author":"Padhani","year":"2017","journal-title":"Eur. Urol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1148\/radiol.2019181949","article-title":"Guidelines for Acquisition, Interpretation, and Reporting of Whole-Body MRI in Myeloma: Myeloma Response Assessment and Diagnosis System (MY-RADS)","volume":"291","author":"Messiou","year":"2019","journal-title":"Radiology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1148\/radiol.2021201740","article-title":"Oncologically Relevant Findings Reporting and Data System (ONCO-RADS): Guidelines for the Acquisition, Interpretation, and Reporting of Whole-Body MRI for Cancer Screening","volume":"299","author":"Petralia","year":"2021","journal-title":"Radiology"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Parillo, M., Santucci, D., Stiffi, M., Faiella, E., Beomonte Zobel, B., and Mallio, C.A. (2024). The Role of Delayed Imaging at MRI in Rare Non-Enhancing Prostate Cancer Brain Metastases: A Case Report. Neurohospitalist, Epub ahead of print.","DOI":"10.1177\/19418744241303538"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/j.ejca.2014.07.002","article-title":"Monitoring the Response of Bone Metastases to Treatment with Magnetic Resonance Imaging and Nuclear Medicine Techniques: A Review and Position Statement by the European Organisation for Research and Treatment of Cancer Imaging Group","volume":"50","author":"Lecouvet","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/pcan.2016.71","article-title":"Radiographic Progression with Nonrising PSA in Metastatic Castration-Resistant Prostate Cancer: Post Hoc Analysis of PREVAIL","volume":"20","author":"Bryce","year":"2017","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1016\/S0959-8049(11)70163-0","article-title":"What Is the Pathophysiology of a Hormone-Resistant Prostate Tumour?","volume":"47","author":"Tombal","year":"2011","journal-title":"Eur. J. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"20170344","DOI":"10.1259\/bjr.20170344","article-title":"Fat Fraction Mapping Using Magnetic Resonance Imaging: Insight into Pathophysiology","volume":"91","author":"Bray","year":"2018","journal-title":"Br. J. Radiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e391","DOI":"10.1016\/j.clgc.2019.12.010","article-title":"METastasis Reporting and Data System for Prostate Cancer as a Prognostic Imaging Marker in Castration-Resistant Prostate Cancer","volume":"18","author":"Yoshida","year":"2020","journal-title":"Clin. Genitourin Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/jmri.27596","article-title":"Metastatic Diffusion Volume Based on Apparent Diffusion Coefficient as a Prognostic Factor in Castration-Resistant Prostate Cancer","volume":"54","author":"Yamamoto","year":"2021","journal-title":"J. Magn. Reson. Imaging"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Van Damme, J., Tombal, B., Michoux, N., Van Nieuwenhove, S., Pasoglou, V., Triqueneaux, P., Padhani, A.R., and Lecouvet, F.E. (2024). Value of Whole-Body Magnetic Resonance Imaging Using the MET-RADS-P Criteria for Assessing the Response to Intensified Androgen Deprivation Therapy in Metastatic Hormone-Na\u00efve and Castration-Resistant Prostate Cancer. Eur. Urol. Oncol., Epub ahead of print.","DOI":"10.1016\/j.euo.2024.10.009"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s40644-020-00350-x","article-title":"Whole-Body Magnetic Resonance Imaging (WB-MRI) Reporting with the METastasis Reporting and Data System for Prostate Cancer (MET-RADS-P): Inter-Observer Agreement between Readers of Different Expertise Levels","volume":"20","author":"Pricolo","year":"2020","journal-title":"Cancer Imaging"},{"key":"ref_30","first-page":"29","article-title":"Analysis of Interreader Agreement in Structured Reports of Pelvic Multiparametric Magnetic Resonance Imaging Using the METastasis Reporting and Data System for Prostate Cancer Guidelines","volume":"29","author":"Liu","year":"2023","journal-title":"Diagn. Interv. Radiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40644-023-00523-4","article-title":"Semiautomated Pelvic Lymph Node Treatment Response Evaluation for Patients with Advanced Prostate Cancer: Based on MET-RADS-P Guidelines","volume":"23","author":"Liu","year":"2023","journal-title":"Cancer Imaging"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.3390\/tomography10070075","article-title":"Fat Fraction Extracted from Whole-Body Magnetic Resonance (WB-MR) in Bone Metastatic Prostate Cancer: Intra- and Inter-Reader Agreement of Single-Slice and Volumetric Measurements","volume":"10","author":"Agazzi","year":"2024","journal-title":"Tomography"},{"key":"ref_33","first-page":"479","article-title":"Application of (18)F-FDG PET and Diffusion Weighted Imaging (DWI) in Multiple Myeloma: Comparison of Functional Imaging Modalities","volume":"5","author":"Sachpekidis","year":"2015","journal-title":"Am. J. Nucl. Med. Mol. Imaging"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/leu.2015.338","article-title":"Whole-Body Diffusion-Weighted MRI: A New Gold Standard for Assessing Disease Burden in Patients with Multiple Myeloma?","volume":"30","author":"Pawlyn","year":"2016","journal-title":"Leukemia"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1365-2141.2011.08658.x","article-title":"Diffusion-Weighted Imaging for Non-Invasive and Quantitative Monitoring of Bone Marrow Infiltration in Patients with Monoclonal Plasma Cell Disease: A Comparative Study with Histology","volume":"153","author":"Hillengass","year":"2011","journal-title":"Br. J. Haematol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1148\/radiol.13131529","article-title":"Whole-Body Diffusion-Weighted MR Imaging for Assessment of Treatment Response in Myeloma","volume":"271","author":"Giles","year":"2014","journal-title":"Radiology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.crad.2015.02.013","article-title":"Assessing Myeloma Bone Disease with Whole-Body Diffusion-Weighted Imaging: Comparison with X-ray Skeletal Survey by Region and Relationship with Laboratory Estimates of Disease Burden","volume":"70","author":"Giles","year":"2015","journal-title":"Clin. Radiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1200\/JCO.2014.57.9961","article-title":"Role of Magnetic Resonance Imaging in the Management of Patients with Multiple Myeloma: A Consensus Statement","volume":"33","author":"Dimopoulos","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1177\/19714009221150849","article-title":"Imaging Findings in a Case of Leptomeningeal Myelomatosis, a Rare but Critical Central Nervous System Complication of Multiple Myeloma","volume":"36","author":"Parillo","year":"2023","journal-title":"Neuroradiol. J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1007\/s00277-020-04265-2","article-title":"Prospective Comparison of 18-FDG PET\/CT and Whole-Body Diffusion-Weighted MRI in the Assessment of Multiple Myeloma","volume":"99","author":"Mesguich","year":"2020","journal-title":"Ann. Hematol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"5859","DOI":"10.1002\/cam4.4136","article-title":"Predictive Role of Diffusion-Weighted Whole-Body MRI (DW-MRI) Imaging Response According to MY-RADS Criteria after Autologous Stem Cell Transplantation in Patients with Multiple Myeloma and Combined Evaluation with MRD Assessment by Flow Cytometry","volume":"10","author":"Belotti","year":"2021","journal-title":"Cancer Med."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Agarwal, G., Nador, G., Varghese, S., Getu, H., Palmer, C., Watson, E., Pereira, C., Sallemi, G., Partington, K., and Patel, N. (2022). Prospective Assessment of Tumour Burden and Bone Disease in Plasma Cell Dyscrasias Using DW-MRI and Exploratory Bone Biomarkers. Cancers, 15.","DOI":"10.3390\/cancers15010095"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2214\/AJR.21.26534","article-title":"Prediction of Early Treatment Response in Multiple Myeloma Using MY-RADS Total Burden Score, ADC, and Fat Fraction From Whole-Body MRI: Impact of Anemia on Predictive Performance","volume":"218","author":"Dong","year":"2022","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"109403","DOI":"10.1016\/j.ejrad.2020.109403","article-title":"The Utility of ADC Value in Diffusion-Weighted Whole-Body MRI in the Follow-up of Patients with Multiple Myeloma. Correlation Study with 18F-FDG PET-CT","volume":"133","author":"Paternain","year":"2020","journal-title":"Eur. J. Radiol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Mesguich, C., Latrabe, V., Hulin, C., Lascaux, A., Bordenave, L., Hindi\u00e9, E., and Marit, G. (2021). Prospective Comparison of 18-FDG PET\/CT and Whole-Body MRI with Diffusion-Weighted Imaging in the Evaluation of Treatment Response of Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplant. Cancers, 13.","DOI":"10.3390\/cancers13081938"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"109154","DOI":"10.1016\/j.ejrad.2020.109154","article-title":"Spectrum of Magnetic Resonance Imaging Findings in Transplanted Multiple Myeloma Patients with Hip\/Pelvic Pain (According to MY-RADS): A Single Center Experience","volume":"130","author":"Rossi","year":"2020","journal-title":"Eur. J. Radiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"20220745","DOI":"10.1259\/bjr.20220745","article-title":"Test-Retest, Inter- and Intra-Rater Reproducibility of Size Measurements of Focal Bone Marrow Lesions in MRI in Patients with Multiple Myeloma","volume":"96","author":"Wennmann","year":"2023","journal-title":"Br. J. Radiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrclinonc.2016.162","article-title":"Imaging Biomarker Roadmap for Cancer Studies","volume":"14","author":"Aboagye","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13244-022-01253-0","article-title":"Implementation of Whole-Body MRI (MY-RADS) within the OPTIMUM\/MUKnine Multi-Centre Clinical Trial for Patients with Myeloma","volume":"13","author":"Rata","year":"2022","journal-title":"Insights Imaging"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s13244-023-01498-3","article-title":"Image Quality in Whole-Body MRI Using the MY-RADS Protocol in a Prospective Multi-Centre Multiple Myeloma Study","volume":"14","author":"Keaveney","year":"2023","journal-title":"Insights Imaging"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1158\/1078-0432.CCR-17-0515","article-title":"Pediatric Cancer Predisposition Imaging: Focus on Whole-Body MRI","volume":"23","author":"Greer","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40644-024-00665-z","article-title":"Applying ONCO-RADS to Whole-Body MRI Cancer Screening in a Retrospective Cohort of Asymptomatic Individuals","volume":"24","author":"Hu","year":"2024","journal-title":"Cancer Imaging"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e70049","DOI":"10.1002\/cam4.70049","article-title":"Feasibility of Whole-Body MRI for Cancer Screening in Children and Young People with Ataxia Telangiectasia: A Mixed Methods Cross-Sectional Study","volume":"13","author":"Neves","year":"2024","journal-title":"Cancer Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/jmri.29461","article-title":"Observations Regarding the Detection of Abnormal Findings Following a Cancer Screening Whole-Body MRI in Asymptomatic Subjects: The Psychological Consequences and the Role of Personality Traits Over Time","volume":"61","author":"Conti","year":"2025","journal-title":"J. Magn. Reson. Imaging"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/2\/275\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:29:38Z","timestamp":1759919378000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/2\/275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,16]]},"references-count":54,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["cancers17020275"],"URL":"https:\/\/doi.org\/10.3390\/cancers17020275","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,16]]}}}